Aristeia Capital’s Exelixis EXEL Stock Holding History

Aristeia Capital’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-57,332	Closed	-$322K	–	60
2015 Q3	$322K	Buy	+57,332	New	+$312K	0.02%	65

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aristeia Capital's EXEL Position: Q4 2015 in Review

Aristeia Capital sold out of Exelixis (EXEL) in Q4 2015, closing a stake of 57,332 shares — an estimated $322K sold.

Aristeia Capital first reported a position in EXEL in Q3 2015 and held it in 1 quarter. The position peaked at $322K in Q3 2015. 146 funds tracked by Wall St. Rank hold EXEL as of Q4 2015.

Aristeia Capital reported no remaining Exelixis position as of Q4 2015 after selling out during the quarter.
Aristeia Capital sold 57,332 Exelixis shares in Q4 2015, an estimated $322K.
Aristeia Capital first reported a position in Exelixis in Q3 2015 and held it in 1 quarter.
Aristeia Capital's Exelixis position peaked at $322K in Q3 2015.
146 funds tracked by Wall St. Rank held Exelixis as of Q4 2015.

Based on Aristeia Capital's 13F filing for Q4 2015, filed 16 Feb 2016.